As shown in Fig. S4C and S4D, treatment with ABBV-075 dose-dependently induced apoptosis to a diverse extent in cultured AML cell lines, including FLT3-ITD and MLL fusion-protein expressing MV4-11 and MOLM13 cells. Here, KMT2A is linked to acute myeloid leukemia.